Metformin Improves Peripheral Insulin Sensitivity in Youth with Type 1 Diabetes

Melanie Cree-Green, Bryan C. Bergman, Eda Cengiz, Larry A. Fox, Tamara S. Hannon, Kellee Miller, Brandon Nathan, Laura Pyle, Darcy Kahn, Michael Tansey, Eileen Tichy, Eva Tsalikian, Ingrid Libman, Kristen J. Nadeau

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Context Type 1 diabetes in adolescence is characterized by insulin deficiency and insulin resistance (IR), both thought to increase cardiovascular disease risk. We previously demonstrated that adolescents with type 1 diabetes have adipose, hepatic, and muscle IR, and that metformin lowers daily insulin dose, suggesting improved IR. However, whether metformin improves IR in muscle, hepatic, or adipose tissues in type 1 diabetes was unknown. Objective Measure peripheral, hepatic, and adipose insulin sensitivity before and after metformin or placebo therapy in youth with obesity with type 1 diabetes. Design Double-blind, placebo-controlled clinical trial. Setting Multi-center at eight sites of the T1D Exchange Clinic Network. Participants A subset of 12- to 19-year-olds with type 1 diabetes (inclusion criteria: body mass index ≥85th percentile, HbA1c 7.5% to 9.9%, insulin dosing ≥0.8 U/kg/d) from a larger trial (NCT02045290) were enrolled. Intervention Participants were randomized to 3 months of metformin (N = 19) or placebo (N = 18) and underwent a three-phase hyperinsulinemic euglycemic clamp with glucose and glycerol isotope tracers to assess tissue-specific IR before and after treatment. Main Outcome Measures Peripheral insulin sensitivity, endogenous glucose release, rate of lipolysis. Results Between-group differences in change in insulin sensitivity favored metformin regarding whole-body IR [change in glucose infusion rate 1.3 (0.1, 2.4) mg/kg/min, P = 0.03] and peripheral IR [change in metabolic clearance rate 0.923 (-0.002, 1.867) dL/kg/min, P = 0.05]. Metformin did not impact insulin suppression of endogenous glucose release (P = 0.12). Adipose IR was not assessable with traditional methods in this highly IR population. Conclusions Metformin appears to improve whole-body and peripheral IR in youth who are overweight/obese with type 1 diabetes.

Original languageEnglish (US)
Pages (from-to)3265-3278
Number of pages14
JournalJournal of Clinical Endocrinology and Metabolism
Volume104
Issue number8
DOIs
StatePublished - Jun 19 2019

    Fingerprint

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Cree-Green, M., Bergman, B. C., Cengiz, E., Fox, L. A., Hannon, T. S., Miller, K., Nathan, B., Pyle, L., Kahn, D., Tansey, M., Tichy, E., Tsalikian, E., Libman, I., & Nadeau, K. J. (2019). Metformin Improves Peripheral Insulin Sensitivity in Youth with Type 1 Diabetes. Journal of Clinical Endocrinology and Metabolism, 104(8), 3265-3278. https://doi.org/10.1210/jc.2019-00129